Tag: Drug Development

Rethinking evidence generation for ultra-rare diseases 

Scientific analyzes results of cerebrospinal fluid in patients with transverse myelitis. FDA’s RDEP in Context Developing treatments for ultra-rare diseases…

Drug development

ADC Development and Market Access

Optimizing ADC value beyond approval through model-informed strategies Originally aired: Thursday, April 2, 2026 As antibody–drug conjugates (ADCs) move from…

Drug development

Strategic Project Management for Accelerated Drug Development

Skip to PDF content Download PDF Learn more about Project Management services Certara’s dedicated project management services complement our core…

Drug development

Modeling and Simulation and RWE in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully representative in age, gender, ethnicity,…

Drug development